Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

News From Washington: IOM report says safety issues point to FDA fund 'imbalance'

Oct. 5, 2006

By Aaron Lorenzo

MacroGenics Gets $63M From Government, Mostly For WNV

Oct. 4, 2006

By Aaron Lorenzo

Gamida Cell Raises $16M To Broaden Its Programs

Oct. 4, 2006

By Aaron Lorenzo

Gamida Cell Raises $16M To Broaden Its Programs

Oct. 4, 2006

By Aaron Lorenzo

MacroGenics Gets $63M From Government, Mostly For WNV

Oct. 4, 2006

By Aaron Lorenzo

PTC Therapeutics Earns $17M For Bioterror Work

Oct. 3, 2006

By Aaron Lorenzo

IOM report: Drug safety issues point to FDA fund ‘imbalance’

Oct. 3, 2006

By Aaron Lorenzo

PTC Therapeutics Earns $17M For Bioterror Work

Oct. 3, 2006

By Aaron Lorenzo

Antiviral Maribavir Moves Into Pivotal Development

Oct. 2, 2006

By Aaron Lorenzo

IOM Report: Poor Funding Cause For Concern At FDA

Oct. 2, 2006

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...